Serial #98358897
LIVE

Serial Number

98358897

Owner

Accord Biopharma, Inc.

Attorney

Michele K. Robichaux

First Use Date

Jan 1, 2024

Filing Date

Jan 16, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98358897 Trademark

Serial Number: 98358897 • Registration: 8274971

Serial #98358897 is a trademark filed by Accord Biopharma, Inc. on January 16, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Accord Biopharma, Inc. (2 trademarks)

8041 Arco Corporate Drive, Suite 200
Raleigh, DE 27617

Entity Type: 03

Trademark Details

Filing Date

January 16, 2024

Registration Date

May 26, 2026

First Use Anywhere

January 1, 2024

First Use in Commerce

January 1, 2025

Published for Opposition

September 17, 2024

Goods & Services

Medical services, namely, providing medical and health information to patients in the areas of oncology, immunology, cardiology, endocrinology, diabetology, pain management, neurology, hematology, dermatology, and critical care

Pharmaceutical preparations and therapeutic pharmaceuticals for use in oncology, immunology, cardiology, endocrinology, diabetology, pain management, neurology, hematology, dermatology, and critical care; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and therapeutic pharmaceuticals for the prevention and treatment of cancer and cancer-related comorbidities; pharmaceuticals used for stimulating white blood cell production; Pharmaceutical preparations for the treatment of bone diseases, infectious diseases, liver disease, obesity, kidney disease, mental health conditions, Alzheimer's disease, respiratory diseases and disorders, skin disorders, asthma, inflammatory diseases, auto-immune and immune-based disorders, cardiovascular disorders, neurological diseases and disorders, auto-immune and immune-based diseases, and critical illness; Pharmaceutical preparations, namely, anti-diabetics, cardiovascular agents, anti-rheumatics, vaccines, anti-viral medications, immunosuppressants, bronchodilators, anti-coagulants, anti-histamines, anti-inflammatory and anti-arthritic preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 1, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 1, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 15, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 15, 2026 AITU
USE AMENDMENT FILED
Nov 11, 2025 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2025 EXRA
TEAS STATEMENT OF USE RECEIVED
Nov 11, 2025 EISU
SOU EXTENSION 2 GRANTED
Nov 11, 2025 EX2G
SOU EXTENSION 2 FILED
Nov 11, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 5, 2025 EX1G
SOU EXTENSION 1 FILED
May 5, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 5, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2025 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 12, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 7, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2024 NWOS
NEW APPLICATION ENTERED
Jan 20, 2024 NWAP